CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating

Positive
AI Analysis

Summary

Jefferies increased its price target for Regeneron Pharmaceuticals from $870 to $930 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.60
price_target_increaseanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on October 2, 2026 1:30 PM

Read Original